FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2155446082> ?p ?o ?g. }

• W2155446082 endingPage "1168" @default.
• W2155446082 startingPage "1162" @default.
• W2155446082 abstract "Cancer cells of microscopic metastases can be envisaged as ideal constituents for the development of a genetically modified, autologous tumor cell vaccine. However, their extremely low number has thus far blocked this approach. The aim of this study was to culture micro-metastatic tumor cells present in bone marrow of patients with various forms of epithelial cancer and to thereby establish immortalized cell lines. Bone marrow aspirates from the upper iliac crest of 152 patients with cancer of the prostate, kidney, lung, breast, or colorectum were cultured at 1 × 10 7 to 6 × 10 7 mononuclear cells (MNC) per flask in fetal calf serum-containing RPMI-1640 medium supplemented with 10 ng/mL epidermal growth factor and 10 ng/mL basic fibroblast growth factor. The proliferation of epithelial cells on extracellular matrix-coated plates was monitored by sampling and staining aliquots with cytokeratin-specific antibodies. After 3–6 weeks in culture, the cells were transferred to Petri dishes, and 200–300 epithelial cells per plate were microinjected with DNA encoding for the simian virus 40 (SV40) large T antigen. Cells were screened at various time points for expression of large T antigen and epithelial markers, such as cytokeratins, prostate-specific antigen, prolactin-inducible protein, or intestinal-specific annexin; their bone marrow-seeking potential was tested in immunodeficient SCID (i.e., severe combined immunodeficiency) mice given subcutaneous transplants of the immortalized cells. Prior to culture, more than 90% of all samples presented with fewer than 10 tumor cells per 8 × 10 5 MNC. In 68 cases (44.7%), the established culture conditions allowed a two to four log transient expansion of these cells with rather small differences among the tumor types studied. Epidermal growth factor and basic fibroblast growth factor were found to be essential for this culture system. After microinjection of the propagated cells with T-antigen DNA, permanent cell lines were obtained; some of these cell lines (prostate and lung cancer cell lines) are now beyond culture passage 80. The cells showed no notable changes in the pattern of expressed epithelial antigens and were able to disseminate into bone marrow in SCID mice. This procedure allows the selective immortalization of micrometastatic carcinoma cells. Integration of SV40 DNA and expression of T antigen did not substantially change the epithelial phenotype of the propagated cells. The established system will allow an in-depth molecular analysis of human micrometastatic cancer cells and could become a useful source for the generation of autologous tumor cell vaccines. [J Natl Cancer Inst 87: 1162–1168, 1995]" @default.
• W2155446082 created "2016-06-24" @default.
• W2155446082 creator A5001528551 @default.
• W2155446082 creator A5014163839 @default.
• W2155446082 creator A5014540305 @default.
• W2155446082 creator A5017310094 @default.
• W2155446082 creator A5032492719 @default.
• W2155446082 creator A5048105827 @default.
• W2155446082 creator A5053928543 @default.
• W2155446082 creator A5065838297 @default.
• W2155446082 creator A5066380716 @default.
• W2155446082 creator A5068350308 @default.
• W2155446082 creator A5077890572 @default.
• W2155446082 date "1995-08-02" @default.
• W2155446082 modified "2023-09-27" @default.
• W2155446082 title "Establishment of Micrometastatic Carcinoma Cell Lines: a Novel Source of Tumor Cell Vaccines" @default.
• W2155446082 doi "https://doi.org/10.1093/jnci/87.15.1162" @default.
• W2155446082 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/7674321" @default.
• W2155446082 hasPublicationYear "1995" @default.
• W2155446082 type Work @default.
• W2155446082 sameAs 2155446082 @default.
• W2155446082 citedByCount "125" @default.
• W2155446082 countsByYear W21554460822013 @default.
• W2155446082 countsByYear W21554460822014 @default.
• W2155446082 countsByYear W21554460822015 @default.
• W2155446082 countsByYear W21554460822016 @default.
• W2155446082 countsByYear W21554460822017 @default.
• W2155446082 countsByYear W21554460822018 @default.
• W2155446082 countsByYear W21554460822020 @default.
• W2155446082 countsByYear W21554460822021 @default.
• W2155446082 countsByYear W21554460822022 @default.
• W2155446082 countsByYear W21554460822023 @default.
• W2155446082 crossrefType "journal-article" @default.
• W2155446082 hasAuthorship W2155446082A5001528551 @default.
• W2155446082 hasAuthorship W2155446082A5014163839 @default.
• W2155446082 hasAuthorship W2155446082A5014540305 @default.
• W2155446082 hasAuthorship W2155446082A5017310094 @default.
• W2155446082 hasAuthorship W2155446082A5032492719 @default.
• W2155446082 hasAuthorship W2155446082A5048105827 @default.
• W2155446082 hasAuthorship W2155446082A5053928543 @default.
• W2155446082 hasAuthorship W2155446082A5065838297 @default.
• W2155446082 hasAuthorship W2155446082A5066380716 @default.
• W2155446082 hasAuthorship W2155446082A5068350308 @default.
• W2155446082 hasAuthorship W2155446082A5077890572 @default.
• W2155446082 hasConcept C142724271 @default.
• W2155446082 hasConcept C147483822 @default.
• W2155446082 hasConcept C153911025 @default.
• W2155446082 hasConcept C203014093 @default.
• W2155446082 hasConcept C2780007613 @default.
• W2155446082 hasConcept C502942594 @default.
• W2155446082 hasConcept C54355233 @default.
• W2155446082 hasConcept C71924100 @default.
• W2155446082 hasConcept C81885089 @default.
• W2155446082 hasConcept C86803240 @default.
• W2155446082 hasConceptScore W2155446082C142724271 @default.
• W2155446082 hasConceptScore W2155446082C147483822 @default.
• W2155446082 hasConceptScore W2155446082C153911025 @default.
• W2155446082 hasConceptScore W2155446082C203014093 @default.
• W2155446082 hasConceptScore W2155446082C2780007613 @default.
• W2155446082 hasConceptScore W2155446082C502942594 @default.
• W2155446082 hasConceptScore W2155446082C54355233 @default.
• W2155446082 hasConceptScore W2155446082C71924100 @default.
• W2155446082 hasConceptScore W2155446082C81885089 @default.
• W2155446082 hasConceptScore W2155446082C86803240 @default.
• W2155446082 hasIssue "15" @default.
• W2155446082 hasLocation W21554460821 @default.
• W2155446082 hasLocation W21554460822 @default.
• W2155446082 hasOpenAccess W2155446082 @default.
• W2155446082 hasPrimaryLocation W21554460821 @default.
• W2155446082 hasRelatedWork W1970707390 @default.
• W2155446082 hasRelatedWork W2027717767 @default.
• W2155446082 hasRelatedWork W2038751394 @default.
• W2155446082 hasRelatedWork W2067699521 @default.
• W2155446082 hasRelatedWork W2220102944 @default.
• W2155446082 hasRelatedWork W2371279320 @default.
• W2155446082 hasRelatedWork W2406768874 @default.
• W2155446082 hasRelatedWork W2414745257 @default.
• W2155446082 hasRelatedWork W4300420468 @default.
• W2155446082 hasRelatedWork W74504067 @default.
• W2155446082 hasVolume "87" @default.
• W2155446082 isParatext "false" @default.
• W2155446082 isRetracted "false" @default.
• W2155446082 magId "2155446082" @default.
• W2155446082 workType "article" @default.